Investment Type

Product Portfolio Acquired by Essential Pharma

Date

November 2021

Location

Leeds, UK

Sector

Healthcare

Industries

Pharmaceuticals

About Rosemont

Essential Pharma completes two transactions with Rosemont Pharmaceuticals bringing into the portfolio several attractive niche products and streamlining the portfolio to pursue strategic growth ambition

Essential Pharma, an international specialty pharma group focused on maintaining access to well-established, “at risk” products essential to patients across multiple therapeutic areas, completed the divestment of its oral liquid portfolio to Rosemont Pharmaceuticals, a UK-based pharmaceutical company focused on manufacturing oral liquid products. Essential has separately acquired a series of attractive, niche products with geographic expansion potential.